We have located links that may give you full text access.
Is a prolonged drug provocation test better than a single-day drug provocation test?: A systematic review and meta-analysis.
Journal of Allergy and Clinical Immunology in Practice 2023 November 23
BACKGROUND: There is currently no standardized duration of drug provocation test (DPT) for confirming/delabeling beta-lactam hypersensitivity reaction (BL-HSR).
OBJECTIVES: This meta-analysis and systematic review aimed to investigate the added diagnostic value of extended-day over single-day DPT for confirming/delabeling BL-HSR in adults and children.
METHODS: The MEDLINE, EMBASE, Web of Science, and CINAHL online databases were searched from inception to 15 March 2023 for studies that performed extended-day DPT to confirm/delabel BL-HSR. Risk difference and risk ratio were used to compare the proportions of patients with confirmed BL-HSR by single-day or extended-day DPT.
RESULTS: A total of 10,371 DPTs from 42 studies were included. Extended-day DPTs ranged from 2-7 days, or as long as index reactions were reported (maximum 10 days). The overall prevalence of confirmed BL-HSR was 6.96% (3.31% during the first-day DPT, and 3.65% during extended-day DPT). Approximately half of positive reactions during extended-day DPT occurred during the second/third day. The increased detected pool prevalence of confirmed BL-HSR yielded by extended-day DPT was 0.03 (95%CI: 0.02-0.04%; I2 =57.69%, p<0.001), and the risk ratio of positive reactions between extended-day and single-day DPT was 1.94 (95%CI: 1.62-2.33; I2 =36.26%, p<0.001). The risk difference increased per 1% increase in prevalence of BL-HSR by 0.6% (95%CI: 0.4-0.7%; p<0.001). Twenty-three severe reactions occurred during DPT, with only 2 severe reactions (0.02%) occurred during extended-day DPT. Additional 28 extended-day DPTs were needed to identify one mild reaction.
CONCLUSION: The increased prevalence of confirmed BL-HSR observed during extended-day DPT could be attributed to the first-day DPT. As a results, our findings do not conclusively support the use of extended-day DPT over single-day DPT. Further studies, incorporating a wash out period, are required to comprehensively compare these two approaches.
OBJECTIVES: This meta-analysis and systematic review aimed to investigate the added diagnostic value of extended-day over single-day DPT for confirming/delabeling BL-HSR in adults and children.
METHODS: The MEDLINE, EMBASE, Web of Science, and CINAHL online databases were searched from inception to 15 March 2023 for studies that performed extended-day DPT to confirm/delabel BL-HSR. Risk difference and risk ratio were used to compare the proportions of patients with confirmed BL-HSR by single-day or extended-day DPT.
RESULTS: A total of 10,371 DPTs from 42 studies were included. Extended-day DPTs ranged from 2-7 days, or as long as index reactions were reported (maximum 10 days). The overall prevalence of confirmed BL-HSR was 6.96% (3.31% during the first-day DPT, and 3.65% during extended-day DPT). Approximately half of positive reactions during extended-day DPT occurred during the second/third day. The increased detected pool prevalence of confirmed BL-HSR yielded by extended-day DPT was 0.03 (95%CI: 0.02-0.04%; I2 =57.69%, p<0.001), and the risk ratio of positive reactions between extended-day and single-day DPT was 1.94 (95%CI: 1.62-2.33; I2 =36.26%, p<0.001). The risk difference increased per 1% increase in prevalence of BL-HSR by 0.6% (95%CI: 0.4-0.7%; p<0.001). Twenty-three severe reactions occurred during DPT, with only 2 severe reactions (0.02%) occurred during extended-day DPT. Additional 28 extended-day DPTs were needed to identify one mild reaction.
CONCLUSION: The increased prevalence of confirmed BL-HSR observed during extended-day DPT could be attributed to the first-day DPT. As a results, our findings do not conclusively support the use of extended-day DPT over single-day DPT. Further studies, incorporating a wash out period, are required to comprehensively compare these two approaches.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app